The Maryland Center for TB Control and Prevention provides technical assistance, laboratory, medical and case management consultation services (physician and nurse) to all 24 local health department TB programs in the state,as well as private providers and other stakeholders. Medications are purchased through the program using state general funds for all active cases, suspects and LTBI cases treated by local health departments (>90% of all cases statewide).
Maryland is a high-incidence state for TB with a five-year average of 202 cases annually (2014-2018); consistently above the overall US case rate (3.5 per 100,000 in 2018 compared to the national rate of 2.8). Over the past five years there has been no substantive overall decline in the Maryland TB case rate (range 2.9-3.7). In 2018, 82% of cases in 2018 were among non-US-born individuals, far exceeding the national average, 1.4% of cases were diagnosed as MDR-TB 15.7% of cases also had diabetes, 1.4% reported homelessness, 8.5% were co-infected with HIV and 2.9% were residents of long-term care facilities.
Expected outcomes, as defined by the CDC, include the following: decreases in TB incidence; increases in patients completing treatment within 12 months; increases in TB cases with HIV and drug susceptibility testing results; increases in testing and treatment for latent TB infection (LTBI); increases in accuracy and completeness of surveillance, genotyping, and whole-genome sequencing data; improvement in turnaround times for specimen receipt and laboratory testing; increases in programs implementing TB elimination plans; and increases in sharing of best practices within and between state/local programs.
Services provided are available statewide to all Maryland residents.